Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Progressive Corp.’s ( PGR - Analyst Report ) earnings per share for the third quarter of 2012 were 46 cents, surging nearly 92% from 24 cents in the year-ago quarter. Results outpaced the Zacks Consensus Estimate of 26 cents. Net income shot up 84% from the third quarter of 2011 to $277.0 million in the quarter.
The company recorded net premiums of $4.24 billion in the quarter under review, up 10% from $3.87 billion in the year-ago quarter. Net premiums earned were $4.05 billion, up 8% from $3.74 billion in the year-ago quarter.
Net realized gains on securities in the quarter were $171.9 million, rebounding form net realized losses of $52.6 million in the year-ago quarter. The combined ratio − the percentage of premiums paid out as claims and expenses − deteriorated 70 basis points from the prior-year quarter to 95.9% in the reported quarter.
Numbers in September
Progressive publishes monthly financial reports. During September, policies in force remained healthy, with the Personal Auto segment increasing 5% year over year but down 0.2% sequentially. Special Lines also increased 4% year over year, though declined 0.2% from the preceding month.
In Personal Auto, Direct Auto reported a profit of 6% year over year but inched down 0.1% from the preceding month. Agency Auto was up 5% year over year but down 0.4% from last month. Progressive’s Commercial Auto segment reported an increase of 2.5% year over year.
Total expenses for the reported month increased 10.5% to $1.19 billion from $1.08 billion in September 2011. The major components contributing to the increase in total expenses were a 12.9% increase in losses and loss adjustment expenses, and a 4% increase in other underwriting expenses and a 1% increase in policy acquisition costs.
Progressive reported book value per share of $10.84, up from $9.37 as of September 30, 2011 and $10.63 as of August 31, 2012.
Return on equity on a trailing 12-month basis was 20.1%, up from 16.9% in September 2011 and 16.7% in August 2012. The debt-to-total-capital ratio was 23.9% as of September 30, 2012, down from 29.6% as of September 30, 2011 and from 24.3% as of August 31, 2012.
The quantitative Zacks #3 Rank (short-term Hold rating) for the company indicates no clear directional pressure on the shares over the near term. Allstate Corporation ( ALL - Analyst Report ) , which closely competes with Progressive, carries Zacks #2 Rank, translating into short term Buy rating.
Read the full reports :
Analyst Report on PGR
Analyst Report on ALL